Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

We compared outcomes from a single-arm study of blinatumomab in adult patients with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia (R/R ALL) with a historical data set from Europe and the United States. Estimates of complete remission (CR) and overall survival (OS) were wei...

Descripción completa

Detalles Bibliográficos
Autores principales: Gökbuget, N, Kelsh, M, Chia, V, Advani, A, Bassan, R, Dombret, H, Doubek, M, Fielding, A K, Giebel, S, Haddad, V, Hoelzer, D, Holland, C, Ifrah, N, Katz, A, Maniar, T, Martinelli, G, Morgades, M, O'Brien, S, Ribera, J-M, Rowe, J M, Stein, A, Topp, M, Wadleigh, M, Kantarjian, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056974/
https://www.ncbi.nlm.nih.gov/pubmed/27662202
http://dx.doi.org/10.1038/bcj.2016.84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056974/
https://www.ncbi.nlm.nih.gov/pubmed/27662202
http://dx.doi.org/10.1038/bcj.2016.84

Ejemplares similares